英国肥胖人群中特发性颅内压增高的研究
该研究利用英国全国性数据库CPRD,提取BMI≥30 kg/m2患者的匿名医疗记录,分析特发性颅内压增高(IIH)的患病率与临床表现。多因素分析显示,贫血(p=0.033)和使用非甾体抗炎药(NSAIDs,p=0.011)是仅有的与IIH独立相关的因素;BMI超过肥胖阈值后继续升高并不独立增加IIH风险。作者结论认为IIH为多因素疾病,在肥胖阈值以上未见既往描述的BMI与IIH之间的「剂量-反应」关系延续。
要点
- 多因素分析中仅贫血(p=0.033)与使用NSAIDs(p=0.011)与IIH独立相关。
- BMI超过肥胖阈值(BMI≥30 kg/m2)后继续升高不独立增加IIH风险。
- 作者认为IIH为多因素疾病,肥胖阈值以上未见BMI与IIH的「剂量-反应」关系延续。
核心结论
- IIH是多因素疾病,有贫血背景及使用NSAIDs者风险增加。
- 在肥胖阈值(BMI≥30 kg/m2)以上的各BMI类别中,既往描述的BMI与IIH之间的「剂量-反应」关系未见延续。
研究设计与样本
- 利用英国全国性数据库临床实践研究数据链(CPRD),提取BMI≥30 kg/m2患者的匿名医疗记录进行分析。
- 研究获监管机构独立科学咨询委员会科学批准,并经卫生研究管理局伦理批准,IRAS项目编号203143,ISAC批准注册号16_140R2。
主要发现
- IIH患者年龄更大,更可能患有外周血管病、缺血性心脏病和贫血,更可能有既往心肌梗死,并使用过NSAIDs和类固醇。
- 校正混杂因素的多因素分析显示,贫血(p=0.033)和使用NSAIDs(p=0.011)是仅有的与IIH独立相关的因素。
- BMI超过肥胖阈值后继续升高不独立增加IIH风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Idiopathic intracranial hypertension (IIH) is a syndrome that is characterized by persistently high intracranial pressure and associated with high rates of morbidity and visual loss. Its exact etiology and clinical picture is poorly understood, but it is known to be associated with obesity. The aim of this study was to investigate the prevalence and clinical manifestations of IIH using a large nationwide database of British subjects. MATERIALS AND METHODS: The anonymized healthcare records of patients with a BMI of ≥ 30 kg/m2 were extracted from the Clinical Practice Research Datalink (CPRD), and analyzed. RESULTS: The patients with IIH were older and more likely to have peripheral vascular disease, ischemic heart disease, and anemia; to have had a previous myocardial infarction; and have used non-steroidal anti-inflammatory drugs (NSAIDs) and steroids. Multivariate analysis with adjustment for confounders showed that anemia (p = 0.033) and the use of NSAIDs (p = 0.011) were the only factors independently associated with IIH. Increases in BMI beyond the threshold of obesity did not independently increase risk of IIH. CONCLUSIONS: IIH is a multifactorial disease; the risk of which is increased in patients with a background of anemia, and those who use NSAIDs. Across BMI categories beyond the threshold for obesity (BMI ≥ 30 kg/m2), there is no continuation of the previously described "dose-response" relationship between BMI and IIH. ETHICAL APPROVAL: Scientific approval for the study was granted from the Regulatory Agency's Independent Scientific Advisory Committee and ethical approval by the Health Research Authority IRAS Project ID: 203143. ISAC approval registration number 16_140R2.
引用
- Ardissino M, Moussa O, Tang A, et al. Idiopathic intracranial hypertension in the British population with obesity. Acta Neurochir (Wien). 2018. PMID: 30564882. doi:10.1007/s00701-018-3772-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。